Turning Point Therapeutics, Inc.
MACROCYCLIC COMPOUNDS AND USES THEREOF
Last updated:
Abstract:
The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.
Status:
Application
Type:
Utility
Filling date:
26 Jul 2018
Issue date:
21 May 2020